X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35) 35
index medicus (25) 25
female (20) 20
male (20) 20
middle aged (17) 17
aged (15) 15
cancer (15) 15
gastroenterology & hepatology (15) 15
adult (14) 14
medicine & public health (14) 14
adenocarcinoma - pathology (12) 12
aged, 80 and over (12) 12
pathology (12) 12
adenocarcinoma (10) 10
gastric mucosa - pathology (10) 10
high-grade dysplasia (10) 10
immunohistochemistry (10) 10
oncology (10) 10
surgery (10) 10
animals (9) 9
stomach neoplasms - pathology (9) 9
biopsy (8) 8
gastroenterology (8) 8
radiofrequency ablation (8) 8
barrett esophagus - pathology (7) 7
barrett's esophagus (7) 7
dysplasia (7) 7
esophageal cancer (7) 7
esophageal neoplasms - pathology (7) 7
esophagus (7) 7
gastric intramucosal ph (7) 7
intramucosal adenocarcinoma (7) 7
intramucosal carcinoma (7) 7
surgical oncology (7) 7
carcinoma (6) 6
classification (6) 6
diagnosis (6) 6
endoscopy (6) 6
esophagectomy (6) 6
precancerous conditions - pathology (6) 6
research (6) 6
tumors (6) 6
adenocarcinoma - surgery (5) 5
barrett esophagus - surgery (5) 5
endoscopic surgery (5) 5
gastroesophageal reflux (5) 5
hepatology (5) 5
intramucosal ph (5) 5
long-term survival (5) 5
metaplasia (5) 5
neoplasm staging (5) 5
photodynamic therapy (5) 5
stomach neoplasms - metabolism (5) 5
adenocarcinoma - diagnosis (4) 4
adolescent (4) 4
carcinogenesis (4) 4
cytokines (4) 4
development and progression (4) 4
endoscopic mucosal resection (4) 4
endoscopic submucosal dissection (4) 4
esophageal neoplasms - surgery (4) 4
follow-up (4) 4
gastric mucosa - metabolism (4) 4
helicobacter pylori (4) 4
intestinal metaplasia (4) 4
intestinal mucosa - pathology (4) 4
intramucosal cancer (4) 4
medical colleges (4) 4
mucosal resection (4) 4
stomach (4) 4
stomach cancer (4) 4
surveillance (4) 4
abdominal surgery (3) 3
ablation (3) 3
adenocarcinoma - metabolism (3) 3
anesthesiology (3) 3
antireflux surgery (3) 3
argon plasma coagulation (3) 3
barrett esophagus - therapy (3) 3
barretts-esophagus (3) 3
carcinomas (3) 3
cardiac-surgery (3) 3
cardiopulmonary bypass - adverse effects (3) 3
care and treatment (3) 3
cell differentiation (3) 3
cell proliferation (3) 3
child (3) 3
colorectal neoplasms - pathology (3) 3
colorectal surgery (3) 3
diagnosis, differential (3) 3
diarrhea (3) 3
esophageal neoplasms - diagnosis (3) 3
esophageal neoplasms - therapy (3) 3
esophagoscopy (3) 3
esophagoscopy - methods (3) 3
exercise (3) 3
expression (3) 3
gastric cancer (3) 3
gastrointestinal epithelial neoplasia (3) 3
genetic aspects (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 4/2008, Volume 15, Issue 4, pp. 1117 - 1123
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 11/2007, Volume 42, Issue 11, pp. 874 - 880
Journal Article
Virchows Archiv, ISSN 0945-6317, 10/2001, Volume 439, Issue 4, pp. 512 - 522
Cancer presumably arises from stem cells, preserved in an undifferentiated status since fetal development, or from a dedifferentiation of mature cells that... 
Dedifferentiation Carcinogenesis Gastric cancer Gastritis Cytokeratin | Medicine & Public Health | Pathology | Cytokeratin | Carcinogenesis | Gastric cancer | Dedifferentiation | Gastritis | STEM-CELLS | INTESTINAL METAPLASIA | gastric cancer | dedifferentiation | MONOCLONAL-ANTIBODY | cytokeratin | BARRETTS-ESOPHAGUS | PATHOLOGY | INTRAMUCOSAL CYSTS | IN-VITRO | carcinogenesis | HELICOBACTER-PYLORI INFECTION | NUCLEAR BETA-CATENIN | TRANSFORMING-GROWTH-FACTOR | MONGOLIAN GERBILS | gastritis | Adenocarcinoma - pathology | Epithelial Cells - metabolism | Gastritis - metabolism | Stomach - embryology | Humans | Middle Aged | Fetus - metabolism | Helicobacter pylori - pathogenicity | Stomach Neoplasms - metabolism | Helicobacter Infections - complications | Male | Stomach Neoplasms - pathology | Stomach - metabolism | Helicobacter Infections - pathology | Keratins - biosynthesis | Adenocarcinoma - metabolism | Gastritis - etiology | Gastritis - pathology | Aged, 80 and over | Gastritis - microbiology | Adult | Female | Child | Disease Models, Animal | Carcinoma in Situ - pathology | Epithelial Cells - pathology | Gestational Age | Metaplasia | Animals | Gerbillinae | Cell Transformation, Neoplastic | Adolescent | Fetus - embryology | Keratin-7 | Aged | Helicobacter pylori - isolation & purification | Carcinoma in Situ - metabolism | Keratin | Stomach cancer
Journal Article
Clinical Transplantation, ISSN 0902-0063, 12/2003, Volume 17, Issue 6, pp. no - no
Susana Díaz | patient survival | renal transplantation | skin infections | pediatric kidney transplantation | brain death | Luis Olmedilla | leukocyte‐platelet complexes | peripheral blood stem cell transplantation | endothelial dysfunction | total cholesterol | TaqMan real‐time PCR | IgA nephropathy | tumour transmission | cytomegalovirus | nephrotoxicity | outcomes | cyclosporin | Th1 | orthotopic liver transplantation | models | prognostic factor | brain anoxia – brain death | leucoencephalopathy | steroid‐resistant rejection | transplant patient management | immunosuppressives | review literature | C4d | lymphoproliferative disorder | clinical outcome | the piggyback technique | pp65 antigenemia | trough levels | live donor nephrectomy | immunofluorescent staining | proportional hazards models | marrow transplantation | small‐for‐size graft | hyperlipidemia | statistical | viral infection | insulin | hepatitis B | hepatitis C | soluble markers | Ulrich Kunzendorf | creatinine | low‐dose tacrolimus | immune cell function testing | steroid free | kidney graft survival | therapeutic drug monitoring | adoptive transfer of immunity | microvasculature | living related donor | non‐heart‐beating | perfusion | hypoglycaemia | laparoscopic donor nephrectomy | marginal organ donors | bacterial infection | transplant vasculopathy | living donor | T cell monitored therapy | ATG | basiliximab | cadaveric kidney transplantation NHBD | graft function | liver transplantation | living donor liver transplantation | epithelioid hemangioendothelioma | chronic allograft nephropathy | early acute rejection | hepatitis B virus | Rituximab therapy | transplant glomerulopathy | organ recipient | immunosuppression | chronic rejection | global and regional haemodynamic monitoring | CMV infection | Jehovah's Witnesses | polyclonal antibodies | endothelial function | flowcytometry | Ratan Jha | ribavirin | renal allograft rupture | rhabdomyolsis | enalapril | Girish Narayan | neutropenia | acute cellular rejection | recurrent HCV | idiopathic interstitial pneumonia | lymphoproliferative disorders | statin | transplantation | aging donor | prednisone | bone mass | questionnaire | biliary complication | heart‐beating | kidney transplantation | segmental glomerulosclerosis | platelet activation | retrospective cohort study | troponin T | induction therapy | psychology | immune response | immunoprophylaxis | plasmapheresis | simultaneous kidney–pancreas transplantation | hepatitis C virus | pharmacokinetics | calcineurine inhibitor | computerized tomography | pharmacokinetic | C2 levels | Javier Sanz | primary graft dysfunction | waitlist time | mini incision | intramucosal pH | transplant rejection | metabolites | stroke | ganciclovir pre‐emptive therapy | Homeostasis Model Assessment (HOMA) | biliary anastomosis | coronary sinus | herpesvirus 8 | hemodialysis | steroids | cyclosporin pharmacokinetics | previous transplants | renal allograft recipients | breath test | neuropsychologic | composite tissue allograft | cold ischemia | recipient graft loss | human–kidney transplantation | gastric emptying | Ignacio Garutti | functional immunosuppression | liver failure | hepatitis B immunoglobulin | drug toxicity | GA mutation | safety | Gerd Offermann | cerebral hemorrhage | cytokines | flow cytometry | organ preservation solutions | logistic regression | Epstein–Barr virus infections | hepatocellular carcinoma | serial gene expression | lymphocytotoxic matching | parathyroid hormone | acute intoxication | apolipoprotein AI | allograft survival | pulmonary haemorrhage | pancreas transplantation | leptin | Sundeep Lakhtakia | calcineurin inhibitors | internal iliac artery | recurrence | steroid avoidance | clinical transplantation | emotional experiences | physical functioning | osteocalcin | dual X‐ray absorptionometry | mycophenolate mofetil | José Pérez‐Peña | vaccination | adefovir dipivoxil | right lobe | fat mass | exercise | C2 monitoring | liver function | hypertonic solutions | hand transplantation | arteriovenous fistula | outcome | cyclosporine | cardiovascular disease | organ donor | lamivudine resistance | prediction model | anti‐CD25 monoclonal antibody | heart transplantation | vitamin D | mycophenolic acid | adenocarcinoma | monoclonal and polyclonal immunoassays | tree‐based model | acute rejection | acute pancreatitis | radiofrequency ablation (RFA) | acyclovir | diabetes | HMG‐CoA reductase inhibitor | daclizumab | lamivudine | subcutaneous continuous glucose monitoring | hyperimmune globulin | chemoembolization | drug interactions | cycloosporine A | renal transplant recipients | TA‐GVHD | solar ultraviolet radiation | transfusion | inflammatory cytokines | body | antidonor antibodies | immunosuppression withdrawal | bone mineral density | kidney | Th2 cytokines | human herpesvirus‐7 | neurotoxicity | gastroesophageal reflux | cycloxygenase‐2 | glomerular hypertrophy | human herpesvirus‐6 | non‐invasive | steroid withdrawal | donor selection | T‐lymphocytes | indocyanine green | stem cell transplantation | pseudoaneurysm | defence strategies | angiitis syndrome | diagnosis | continuous venovenous haemodiafiltration | diarrhea | rejection | allograft fracture | early mortality | positive crossmatch | survey | extended donor | cadaveric donor | HLA | quality of life | graft reinfection | complication | cocaine | transforming growth factor beta | peritubular capillary | graft survival | diabetes mellitus | splanchnic circulation | United Network of Organ Sharing | José M. Barrio | Helicobacter pylori | Sanjay Sinha | survival analysis | nucleoside analogues | pathology and clinical correlations | cardiac output measurement | glucocorticoids | urodynamic | side‐effects | Birgit Esslinger | tacrolimus | fibrosing cholestatic hepatitis | kidney transplant | immune monitoring | meta‐analysis | interferon | glottis oedema | risk factor | flow‐mediated dilatation | liver histology | biopsy | domino transplant | renal function | lung transplantation | Margarete Goppelt‐Struebe | giant lymph node hyperplasia | organ preservation
Journal Article
Clinical Transplantation, ISSN 0902-0063, 12/2003, Volume 17, Issue 6, pp. 560 - 560
Susana Díaz | patient survival | renal transplantation | skin infections | pediatric kidney transplantation | brain death | Luis Olmedilla | leukocyte‐platelet complexes | peripheral blood stem cell transplantation | endothelial dysfunction | total cholesterol | TaqMan real‐time PCR | IgA nephropathy | tumour transmission | cytomegalovirus | nephrotoxicity | outcomes | cyclosporin | Th1 | orthotopic liver transplantation | models | prognostic factor | brain anoxia – brain death | leucoencephalopathy | steroid‐resistant rejection | transplant patient management | immunosuppressives | review literature | C4d | lymphoproliferative disorder | clinical outcome | the piggyback technique | pp65 antigenemia | trough levels | live donor nephrectomy | immunofluorescent staining | proportional hazards models | marrow transplantation | small‐for‐size graft | hyperlipidemia | statistical | viral infection | insulin | hepatitis B | hepatitis C | soluble markers | Ulrich Kunzendorf | creatinine | low‐dose tacrolimus | immune cell function testing | steroid free | kidney graft survival | therapeutic drug monitoring | adoptive transfer of immunity | microvasculature | living related donor | non‐heart‐beating | perfusion | hypoglycaemia | laparoscopic donor nephrectomy | marginal organ donors | bacterial infection | transplant vasculopathy | living donor | T cell monitored therapy | ATG | basiliximab | cadaveric kidney transplantation NHBD | graft function | liver transplantation | living donor liver transplantation | epithelioid hemangioendothelioma | chronic allograft nephropathy | early acute rejection | hepatitis B virus | Rituximab therapy | transplant glomerulopathy | organ recipient | immunosuppression | chronic rejection | global and regional haemodynamic monitoring | CMV infection | Jehovah's Witnesses | polyclonal antibodies | endothelial function | flowcytometry | Ratan Jha | ribavirin | renal allograft rupture | rhabdomyolsis | enalapril | Girish Narayan | neutropenia | acute cellular rejection | recurrent HCV | idiopathic interstitial pneumonia | lymphoproliferative disorders | statin | transplantation | aging donor | prednisone | bone mass | questionnaire | biliary complication | heart‐beating | kidney transplantation | segmental glomerulosclerosis | platelet activation | retrospective cohort study | troponin T | induction therapy | psychology | immune response | immunoprophylaxis | plasmapheresis | simultaneous kidney–pancreas transplantation | hepatitis C virus | pharmacokinetics | calcineurine inhibitor | computerized tomography | pharmacokinetic | C2 levels | Javier Sanz | primary graft dysfunction | waitlist time | mini incision | intramucosal pH | transplant rejection | metabolites | stroke | ganciclovir pre‐emptive therapy | Homeostasis Model Assessment (HOMA) | biliary anastomosis | coronary sinus | herpesvirus 8 | hemodialysis | steroids | cyclosporin pharmacokinetics | previous transplants | renal allograft recipients | breath test | neuropsychologic | composite tissue allograft | cold ischemia | recipient graft loss | human–kidney transplantation | gastric emptying | Ignacio Garutti | functional immunosuppression | liver failure | hepatitis B immunoglobulin | drug toxicity | GA mutation | safety | Gerd Offermann | cerebral hemorrhage | cytokines | flow cytometry | organ preservation solutions | logistic regression | Epstein–Barr virus infections | hepatocellular carcinoma | serial gene expression | lymphocytotoxic matching | parathyroid hormone | acute intoxication | apolipoprotein AI | allograft survival | pulmonary haemorrhage | pancreas transplantation | leptin | Sundeep Lakhtakia | calcineurin inhibitors | internal iliac artery | recurrence | steroid avoidance | clinical transplantation | emotional experiences | physical functioning | osteocalcin | dual X‐ray absorptionometry | mycophenolate mofetil | José Pérez‐Peña | vaccination | adefovir dipivoxil | right lobe | fat mass | exercise | C2 monitoring | liver function | hypertonic solutions | hand transplantation | arteriovenous fistula | outcome | cyclosporine | cardiovascular disease | organ donor | lamivudine resistance | prediction model | anti‐CD25 monoclonal antibody | heart transplantation | vitamin D | mycophenolic acid | adenocarcinoma | monoclonal and polyclonal immunoassays | tree‐based model | acute rejection | acute pancreatitis | radiofrequency ablation (RFA) | acyclovir | diabetes | HMG‐CoA reductase inhibitor | daclizumab | lamivudine | subcutaneous continuous glucose monitoring | hyperimmune globulin | chemoembolization | drug interactions | cycloosporine A | renal transplant recipients | TA‐GVHD | solar ultraviolet radiation | transfusion | inflammatory cytokines | body | antidonor antibodies | immunosuppression withdrawal | bone mineral density | kidney | Th2 cytokines | human herpesvirus‐7 | neurotoxicity | gastroesophageal reflux | cycloxygenase‐2 | glomerular hypertrophy | human herpesvirus‐6 | non‐invasive | steroid withdrawal | donor selection | T‐lymphocytes | indocyanine green | stem cell transplantation | pseudoaneurysm | defence strategies | angiitis syndrome | diagnosis | continuous venovenous haemodiafiltration | diarrhea | rejection | allograft fracture | early mortality | positive crossmatch | survey | extended donor | cadaveric donor | HLA | quality of life | graft reinfection | complication | cocaine | transforming growth factor beta | peritubular capillary | graft survival | diabetes mellitus | splanchnic circulation | United Network of Organ Sharing | José M. Barrio | Helicobacter pylori | Sanjay Sinha | survival analysis | nucleoside analogues | pathology and clinical correlations | cardiac output measurement | glucocorticoids | urodynamic | side‐effects | Birgit Esslinger | tacrolimus | fibrosing cholestatic hepatitis | kidney transplant | immune monitoring | meta‐analysis | interferon | glottis oedema | risk factor | flow‐mediated dilatation | liver histology | biopsy | domino transplant | renal function | lung transplantation | Margarete Goppelt‐Struebe | giant lymph node hyperplasia | organ preservation
Journal Article
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 08/1986, Volume 32, Issue 4, pp. 214 - 219
Gastric specimens from 259 patients (69 Swedish and 190 Japanese) were examined for the presence of intramucosal cysts. The number of cysts for each centimeter... 
stomach, carcinogenesis | intramucosal cysts | Sweden | Adenocarcinoma - pathology | Ethnic Groups | Humans | Japan | Stomach Ulcer - pathology | Gastric Mucosa - pathology | Male | Precancerous Conditions - pathology | Stomach Diseases - pathology | Stomach Neoplasms - pathology | Cysts - pathology
Journal Article
Gut, ISSN 0017-5749, 06/2011, Volume 60, Issue 6, pp. 765 - 773
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 11/2017, Volume 52, Issue 11, pp. 1158 - 1168
Journal Article